Even with more restrictive assumptions, the analysis still showed a substantial treatment gap, with only 14.2% of patients ...

Colistin is a polymyxin antibiotic used as a last-resort treatment for severe infections caused by multidrug-resistant Gram-negative bacteria such as Escherichia coli and Pseudomonas aeruginosa. Due ...